NCT05588492View on ClinicalTrials.gov

The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pulmonology
Interventions
DRUG

Rifamycin-containing regimen

Rifamycin-containing regimen

DRUG

Rifamycin-free regimen

Rifamycin-free regimen

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER